Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4127908
Reference Type
Journal Article
Title
Nano carrier mediated co-delivery of dapsone and clofazimine for improved therapeutic efficacy against tuberculosis in rats
Author(s)
Li, HZhi; Ma, ShuH; Zhang, HanM; Liu, JMin; Wu, YanXia; Cao, PeiQ; Gao, X
Year
2017
Is Peer Reviewed?
1
Journal
Biomedical Research
ISSN:
0970-938X
EISSN:
0976-1683
Volume
28
Issue
3
Page Numbers
1284-1289
Web of Science Id
WOS:000396822900055
Abstract
Dapsone and clofazimine is a known therapeutically effective combination against various Mycobacterium species. However, anti-tubercular effect of this combination is limited due to the low aqueous solubility of clofazimine and production of toxic metabolites after first pass metabolism of dapsone following oral route of administration. Therefore, the aim of this investigation was to develop poly-(lactide-co-glycolic acid) nanoparticles (DCNPS) of dapsone and clofazimine. Nanoparticles were prepared using emulsion solvent evaporation method. Developed DCNPSs were characterized for particle size, zeta potential (Zp), morphology and in vitro release. Positively charged (Zp 27.4 mV) DCNPSs with uniform spherical shape depicted controlled release of dapsone (82%) and clofazimine (68%) after 24h. DCNPS showed significantly improved in vivo efficacy against Mycobacterium tuberculosis H37Rv strain infected small animal model than that of drug solution (DCS) as bacterial loads in the lungs (Log10 of CFU/g) was reduced to 2.7 +/- 0.34 (DCNPS) and 4.9 +/- 0.21 (DCS) from 6.8 +/- 0.23 (diseased control). In vitro therapeutic doses of dapsone and clofazimine in both DCS and DCNPS were found to be very safe to use following intravenous route of administration. DCNPS offered an effective mean of introducing safe delivery of dapsone and clofazimine systemically with enhanced in vivo efficacy against H37Rv strain of Mycobacterium tuberculosis.
Keywords
Dapsone; Clofazimine; Nanoparticle; Tuberculosis; Chitosan; PLGA
Tags
IRIS
•
Nitrate/Nitrite
Literature Search Update, 1/1/2016 – 12/31/2017
WoS
Broad LitSearch 2016/1/1 - 2017/12/5
Refs found by LitSearch but not ATSDR/IARC
WoS
Refs found only by 2017 LitSearch or Citation Mapping
Ref Types 12/2017
All Others
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity